Atacand and Gastrointestinal carcinoma - a phase IV clinical study of FDA data

Summary:

Gastrointestinal carcinoma is reported as a side effect among people who take Atacand (candesartan cilexetil), especially for people who are male, 60+ old, have been taking the drug for 1 - 2 years also take Pradaxa, and have Atrial fibrillation/flutter.

The phase IV clinical study analyzes which people have Gastrointestinal carcinoma when taking Atacand. It is created by eHealthMe based on reports of 21,732 people who have side effects when taking Atacand from the FDA, and is updated regularly.

What is Atacand?

Atacand has active ingredients of candesartan cilexetil. It is often used in high blood pressure. eHealthMe is studying from 22,473 Atacand users. Check the latest studies of Atacand.

What is Gastrointestinal carcinoma?

Gastrointestinal carcinoma (cancer of stomach or intestine) is found to be associated with 236 drugs and 345 conditions by eHealthMe. Check the latest studies of Gastrointestinal carcinoma.

On Jul, 17, 2026

21,732 people reported to have side effects when taking Atacand.
Among them, 14 people (0.06%) have Gastrointestinal carcinoma.

Could Atacand cause Gastrointestinal carcinoma?

Among these 14 people:

How long have people been on Atacand when they have Gastrointestinal carcinoma? *

What is the gender of people who have Gastrointestinal carcinoma when taking Atacand? *

female: 38.46 %
male: 61.54 %

What is the age of people who have Gastrointestinal carcinoma when taking Atacand? *

What are other drugs people take besides Atacand? *

What are other side effects people have besides Gastrointestinal carcinoma? *

Anaemia (lack of blood): 5 people, 35.71%
Paleness (unusual lightness of skin colour): 4 people, 28.57%
Dizziness: 4 people, 28.57%
Weakness: 4 people, 28.57%
Occult Blood (blood in the faeces that is not visibly apparent): 4 people, 28.57%
Malaise (a feeling of general discomfort or uneasiness): 4 people, 28.57%
Drug Ineffective: 3 people, 21.43%
Stable Angina (a constant chest pain): 2 people, 14.29%
Left Ventricular Hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart): 2 people, 14.29%
Barrett's Oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach): 2 people, 14.29%

What are the existing conditions these people have? *

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 5 people, 35.71%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 35.71%
Diabetes: 3 people, 21.43%
Oedema (fluid collection in tissue): 2 people, 14.29%
High Blood Cholesterol: 2 people, 14.29%
Barrett's Oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach): 2 people, 14.29%
Arrhythmias (irregular heartbeat): 2 people, 14.29%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 7.14%
Intraocular Pressure Increased: 1 person, 7.14%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Atacand and have Gastrointestinal carcinoma?

- Check whether Gastrointestinal carcinoma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Atacand:

Atacand (22,473 reports)

Browse all side effects of Atacand:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Gastrointestinal carcinoma:

Gastrointestinal carcinoma (236 drugs)

Browse all the conditions that are associated with Gastrointestinal carcinoma:

Gastrointestinal carcinoma (345 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on candesartan cilexetil (the active ingredients of Atacand) and Atacand (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.